Fine J M, Lambin P, Derycke C, North M L, Chataing B, Goudemand M
Rev Fr Transfus Immunohematol. 1978 Sep;21(4):973-9. doi: 10.1016/s0338-4535(78)80054-3.
A routine screening of monoclonal gammopathies (M.G.) was performed in the serum from 36, 015 blood donors by cellulose acetate electrophoresis. The incidence of M.G. was estimated to 0.14 per cent. About 86 per cent of cases can be classified as asymptomatic M.G. and 14 per cent as malignant M.G. (myeloma or Waldenström macroglobulinemia). In asymptomatic forms, heavy chain classes are only IgG or IgM with a large predominance of IgG (86,4%). It is suggested that donors in whom M.G. have been detected should not be allowed to give blood. A yearly clinical, hematological and an immunoglobulin check-up is recommended to these patients in order to defect the first sign of a malignant process.
通过醋酸纤维素电泳对36015名献血者的血清进行了单克隆丙种球蛋白病(M.G.)的常规筛查。M.G.的发病率估计为0.14%。约86%的病例可归类为无症状M.G.,14%为恶性M.G.(骨髓瘤或华氏巨球蛋白血症)。在无症状形式中,重链类别仅为IgG或IgM,其中IgG占主导地位(86.4%)。建议已检测出M.G.的献血者不得献血。建议对这些患者每年进行临床、血液学和免疫球蛋白检查,以便发现恶性病变的首个迹象。